Oppenheimer Weighs in on Humana Inc’s FY2018 Earnings (HUM)
Humana Inc (NYSE:HUM) – Equities researchers at Oppenheimer boosted their FY2018 earnings estimates for shares of Humana in a research report issued on Wednesday, November 7th. Oppenheimer analyst M. Wiederhorn now expects that the insurance provider will earn $14.40 per share for the year, up from their prior estimate of $14.15. Oppenheimer also issued estimates for Humana’s Q3 2019 earnings at $5.09 EPS and FY2019 earnings at $17.23 EPS.
Several other analysts have also issued reports on the company. Morgan Stanley upped their target price on Humana from $400.00 to $418.00 and gave the stock a “buy” rating in a research note on Thursday. BMO Capital Markets set a $390.00 target price on Humana and gave the stock a “buy” rating in a research note on Thursday. Royal Bank of Canada upped their target price on Humana from $318.00 to $349.00 and gave the stock a “sector perform” rating in a research note on Thursday. Credit Suisse Group upped their target price on Humana from $370.00 to $390.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, Bank of America upped their target price on Humana from $400.00 to $415.00 and gave the stock a “buy” rating in a research note on Thursday. Seven analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $352.30.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.29 by $0.29. The business had revenue of $14.21 billion during the quarter, compared to analyst estimates of $13.97 billion. Humana had a return on equity of 19.36% and a net margin of 2.70%. During the same quarter in the prior year, the firm earned $3.39 earnings per share.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Monday, December 31st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date is Friday, December 28th. Humana’s dividend payout ratio (DPR) is presently 17.08%.
In other news, CEO Bruce D. Broussard sold 18,000 shares of the stock in a transaction that occurred on Monday, September 10th. The stock was sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the completion of the sale, the chief executive officer now owns 71,085 shares of the company’s stock, valued at $23,362,796.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Elizabeth D. Bierbower sold 3,092 shares of the stock in a transaction that occurred on Thursday, August 16th. The shares were sold at an average price of $330.00, for a total value of $1,020,360.00. Following the sale, the insider now directly owns 14,289 shares of the company’s stock, valued at approximately $4,715,370. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. Stratos Wealth Partners LTD. purchased a new stake in Humana in the third quarter worth $108,000. Sun Life Financial INC lifted its stake in Humana by 120.7% in the second quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after acquiring an additional 204 shares during the period. Migdal Insurance & Financial Holdings Ltd. lifted its stake in Humana by 2,984.6% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 388 shares during the period. Smithfield Trust Co. lifted its stake in Humana by 531.2% in the third quarter. Smithfield Trust Co. now owns 486 shares of the insurance provider’s stock worth $165,000 after acquiring an additional 409 shares during the period. Finally, Girard Partners LTD. purchased a new stake in Humana in the third quarter worth $169,000. 92.62% of the stock is owned by hedge funds and other institutional investors.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.